GlaxoSmithKline PLC banner

GlaxoSmithKline PLC
XETRA:GS7

Watchlist Manager
GlaxoSmithKline PLC Logo
GlaxoSmithKline PLC
XETRA:GS7
Watchlist
Price: 15.22 EUR -3.08% Market Closed
Market Cap: €61.9B

Intrinsic Value

GS7 price has not been updated for more than 4 months. This may indicate that the stock has been delisted.

The intrinsic value for GlaxoSmithKline PLC (GS7) under the Base Case is 16.67 EUR. Compared with the current market price of 15.22 EUR, the stock appears Undervalued by 9% .

Based on two methods:

DCF suggests overvaluation, while multiples suggest undervaluation.

GS7 Intrinsic Value
16.67 EUR
Undervaluation 9%
Intrinsic Value
Price €15.22
Bear Case
Base Case
Bull Case
Monitor GS7
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €13.33
Get notified when the price drops into your buy zone
Intrinsic Value €16.67
Current Price €15.22
Margin of Safety 20% €13.33
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about GS7?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is GS7 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for GlaxoSmithKline PLC.

Explain Valuation
Alternatives to GS7

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one GS7 stock?

The intrinsic value for GlaxoSmithKline PLC (GS7) under the Base Case is 16.67 EUR.

Is GS7 stock undervalued or overvalued?

Compared with the current market price of 15.22 EUR, the stock appears Undervalued by 9% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett